ABSTRACT. In various human tumors, a metal binding protein, metallothionein (MT) is reported to play an important role in carcinogenesis. In the present preliminary study, MT expression and tumor growth were investigated in transplantable pregnancy-independent mammary tumors (TPIMT) derived from pregnancy-independent mammary tumors (PIMT) in GR/A mice, in order to study the possible role of MT in mammary carcinogenesis. TPIMT as well as PIMT showed MT expression in tumor cells in all of the successive transplantations. A negative correlation was observed between MT expression in transplanted tumor tissues and their growth in the hosts (r = -0 .53, p<0.05). The present study indicates that MT is a useful marker of tumor progression in TPIMT. KEY WORDS: metallothionein, progression, transplantable pregnancy-independent mouse mammary tumor.
Metallothioneins (MTs) are a family of cysteine rich, low molecular-weight proteins with high binding affinity to metal ions, such as zinc, copper, and other group II heavy metal ions. It is known that MT plays important roles in various physiological processes, e.g., detoxification of toxic metal ions and cellular protection against ionizing radiation [10, 13] . In addition, differential MT expression in various human tumors indicates the involvement of MT in carcinogenesis [1, 3, 12, 21, [28] [29] [30] . In transplantable mammary tumor lines in DDD mice, we have demonstrated a negative correlation between MT contents and tumor progression [25, 26] .
Pregnancy-dependent mouse mammary tumors (PDMT) in the GR/A strain appear in mid-pregnancy and continue to grow until the end of pregnancy. PDMT regresses soon after parturition regardless of the onset of lactation, and appears again at subsequent pregnancies [7, 11, 18, 19, 24, 27] . The PDMT is known to transform into the pregnancyindependent autonomous mammary tumor (PIMT) after several deliveries. Since the PIMT is transplantable (Yamamura and Ohta, unpublished data), we examined the relationship between MT expression and tumor growth as a part of our efforts to establish a new transplantable mammary tumor line in GR/A mice.
GR/A mice were kept under 14 hr light/10 hr dark conditions at 22-24°C at Tottori University. Standard laboratory feed (CE-2, CLEA, Tokyo) and tap water were given ad libitum. The mouse care and handling conformed to the NIH guidelines for Animal Research. PIMT samples of the spontaneous mammary tumors were collected for transplantation and immunohistochemical study from three mice at 6 to 7 months of age (corresponding to three tumor lines, A, B and C ). Virgin females aged 60 to 70 days were given a subcutaneous transplant of the tumor piece (approximately 3 × 3 × 3 mm in size) under the dorsal skin. Some of the samples were fixed in Bouin's solution. Transplantable PIMTs (TPIMT) were dissected out when their long diameter grew to approximately 15 mm. The tumors recovered from each host were likewise treated and transplanted serially for 5 generations. The tumor volume was calculated as a rotation ellipsoid (πab 2 /6; a, b = long and short diameters). The growth rate of tumors was estimated by dividing the value of the tumor volume by the number of growing days (mm 3 /day). Tumor tissues fixed in Bouin's solution were embedded in paraffin and sectioned at 4 µm thickness. The sections were treated with anti-MT monoclonal antibody (100 times dilution with phosphate-buffered saline, PBS, Dako Japan, Kyoto, Japan) for 16 hr at 4°C, and then with horseradish peroxidase-labeled anti-mouse IgG sheep F(ab') 2 (50 times dilution with PBS, Amersham Pharmacia Biotec, Buckinghamshire, U.K.). For improvement of the staining pattern, the antigen retrieval technique in a citrate buffer at pH 6.0 for 5 min in an autoclave was essential [25] . Immunoreaction was visualized with diaminobenzidine tetrahydrochloride by the method of Straus [22] . Control sections were incubated with normal serum instead of antibody. The slides were counterstained with hematoxylin (Merck, Darmstadt, Germany). The number of MT positive cells were counted separately in 5 regions from 5 transverse sections of 3 PIMT and 12 TPIMT samples. Expression of MT was estimated by calculating the ratio of positive cells per 500 to 1,000 tumor cells as the MT index (%). Correlation between the MT index and tumor growth rate was analyzed with a statistical software package, StatView IV (Abacus Concepts, Inc., Berkeley, CA). Differences between means at the p<0.05 level were considered significant.
PIMT and TPIMT dissected out after a serial transplantation were composed of ductal, lobular and alveolar struc-tures which were lined with multiple layers of many cuboidal epithelial cells and a few columnar cells. The epithelial strands were separated by loose networks of myoepithelial cells. MT expression was exhibited in the nucleus and/or cytoplasm of the tumor cells but not in the myoepithelial cells (Fig. 1) .
In all TPIMT lines, the growth rate and MT expression estimated by the MT index varied in each generation of the transplantation, and showed no linear change with the advancing transplant generation (Figs. 2 and 3) . However, comparison of MT expression in donor tissues and their growth in the hosts revealed that a negative correlation was observed between the MT index and the growth rate (r = -0.53, p<0.05) (Fig. 4) .
MT expression has been observed in various human tumors, e.g., testicular tumors [12] , malignant melanoma [28, 29] and hepatocellular carcinoma [3] . In breast carcinoma, MT over-expression was observed in tumor cells, suggesting that MT could be a useful marker for tumor progression accompanied with poor prognosis [4-6, 8, 9, 21] . In a previous study, however, Yamamura et al. reported that there was a negative correlation between MT contents and tumor progression in transplantable mammary tumor lines established in DDD mice (e.g., TPDMT-4 and T4-OI96) [25, 26] . TPDMT-4 is a pregnancy-dependent benign mammary tumor line [14, 16] , while T4-OI96 is a pregnancyindependent malignant tumor line established from TPDMT-4 [15, 23, 25, 26] . These tumor lines are well established [14, 23] , and exhibit MT expression in a consistent manner: TPDMT-4 invariably shows MT expression, while T4-OI96 shows little or no MT expression [25] .
In the present study, TPIMT showed different growth and MT expression in each line through the 5 transplant generations, indicating that TPIMT passaged 5 times is still a heterogeneous tumor line. It is worthy of note that in these tumor lines, an inverse correlation was observed between MT expression in transplanted tumor tissues and their growth in hosts. These findings suggest that MT could be used as a potential marker for tumor malignancy.
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